Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ImaRx reports discoveries related to gene expression enhancement

March 10, 1997

Incyte's LifeSeq database licensed to another top pharmaceutical company

March 7, 1997

MorphoSys/P&U drug and target discovery collaboration

March 6, 1997

Cell Genesys licenses gene activation technology

March 6, 1997

Protein Design Labs grants license to Biogen for humanized antibodies

March 5, 1997

GenPharm and Centocor to codevelop human antibodies

March 5, 1997

Vyrex and SeqWright collaborate to develop CD-Tagging technology

March 4, 1997

Incyte and OncorMed to collaborate on clinical genomics

March 3, 1997

Phogen formed to investigate new drug delivery concept

March 3, 1997

Lilly and Emisphere sign agreement

Feb. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...